Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 4
1(25.0%)
Phase 3
1(25.0%)
4Total
N/A(2)
Phase 4(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07552246Phase 4Not Yet Recruiting

Comparing Acupuncture With Medication to Reduce Anxiety and Depression in China

Role: collaborator

NCT07505056Phase 3Not Yet Recruiting

Jianpi Lishi Jiedu Granules for Prevention of Postoperative Recurrence in Colorectal Advanced Adenomas

Role: collaborator

NCT06713421Not ApplicableRecruiting

Effect of Premedication With Pronase on Mucosal Cleanliness During EGD

Role: collaborator

NCT05651893Not ApplicableUnknown

Efficacy of Second Forward-view Examination of Left Colon for Adenoma Detection During Colonoscopy

Role: collaborator

NCT04989153Unknown

Nasal Endoscopic Screening and Risk Assessment for Early Gastric Cancer

Role: collaborator

All 5 trials loaded